Advancements in Dalpiciclib for the Treatment of Breast Cancer Patients: A Review
Zhimin Chen,1,2 Pengjun Xie,1,2 Qihai Chen,1,2 Jie Ouyang1– 3 1The First Clinical Medical College of Guangdong Medical University, Zhanjiang, People’s Republic of China; 2Department of Breast Surgery, Dongguan Dungwah Hospital, Dongguan, People’s Republic of China; 3Dongguan Key Laboratory of Breast...
Saved in:
Main Authors: | Chen Z, Xie P, Chen Q, Ouyang J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-06-01
|
Series: | Breast Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/advancements-in-dalpiciclib-for-the-treatment-of-breast-cancer-patient-peer-reviewed-fulltext-article-BCTT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: A prospective pilot study
by: Yu Zhang, et al.
Published: (2025-07-01) -
Our Experience and Literature Update Regarding Concomitant Radiotherapy with CDK4/6 Inhibitors and Hormonal Therapy in Metastatic Breast Cancer
by: Laura-Florentina Rebegea, et al.
Published: (2025-05-01) -
Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations
by: E. N. Imyanitov
Published: (2016-09-01) -
Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors
by: Zehra Sucuoğlu İşleyen, et al.
Published: (2025-07-01) -
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors
by: Roberta Scafetta, et al.
Published: (2025-08-01)